Get the Stockscreener App
1.69
4.52%
-0.08
After Hours:
1.66
-0.03
-1.78%
Lifeward Ltd stock is traded at $1.69, with a volume of 252.52K.
It is down -4.52% in the last 24 hours and down -3.43% over the past month.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.
See More
Previous Close:
$1.77
Open:
$1.72
24h Volume:
252.52K
Relative Volume:
0.10
Market Cap:
$18.82M
Revenue:
$23.28M
Net Income/Loss:
$-23.75M
P/E Ratio:
-0.5541
EPS:
-3.05
Net Cash Flow:
$-25.22M
1W Performance:
-7.65%
1M Performance:
-3.43%
6M Performance:
-45.48%
1Y Performance:
-66.80%
1-Day Range:
$1.6545
$1.78
1-Week Range:
$1.6545
$1.92
52-Week Range:
$1.25
$6.00
Lifeward Ltd Stock (LFWD) Company Profile
Name
Lifeward Ltd
Sector
Industry
Phone
15082511154
Address
200 DONALD LYNCH BLVD., MARLBOROUGH
Compare LFWD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
1.69 | 18.82M | 23.28M | -23.75M | -25.22M | -3.05 |
|
ABT
Abbott Laboratories
|
131.93 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Initiated | Laidlaw | Buy |
| Apr-03-17 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-16-16 | Initiated | Oppenheimer | Outperform |
| Jul-15-16 | Initiated | Piper Jaffray | Overweight |
| May-22-15 | Upgrade | Canaccord Genuity | Hold → Buy |
| May-08-15 | Reiterated | Barclays | Equal Weight |
| Oct-07-14 | Initiated | Barclays | Equal Weight |
View All
Lifeward Ltd Stock (LFWD) Latest News
Lifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton - TradingView
Lifeward gains FDA clearance for new ReWalk exoskeleton - Investing.com
Sector Update: Health Care Stocks Softer Thursday Afternoon -March 13, 2025 at 02:06 pm EDT - Marketscreener.com
Sector Update: Health Care -March 13, 2025 at 01:43 pm EDT - Marketscreener.com
What's Going On With Lifeward Shares Thursday?Lifeward (NASDAQ:LFWD) - Benzinga
FDA Approval of ReWalk7 Sends Lifeward (LFWD) Stock Climbing - Stocks Telegraph
Lifeward announces FDA clearance for ReWalk 7 exoskeleton - TipRanks
Lifeward Receives FDA Clearance for ReWalk 7 Exoskeleton; Shares Jump -March 13, 2025 at 09:41 am EDT - Marketscreener.com
Lifeward gains FDA clearance for new ReWalk exoskeleton By Investing.com - Investing.com UK
FDA Issues Clearance for ReWalk 7 Exoskeleton - GlobeNewswire
Revolutionary ReWalk 7 Exoskeleton Gets FDA Green Light, Medicare Coverage Ready - StockTitan
Nasdaq Down Over 100 Points; US Producer Inflation Stalls In February - Benzinga
Lifeward stock holds Buy rating and $13 target from H.C. Wainwright - Investing.com Australia
Positive Outlook for Lifeward Driven by Strategic Partnerships and Market Expansion Initiatives - TipRanks
Lifeward stock holds Buy rating and $13 target from H.C. Wainwright By Investing.com - Investing.com South Africa
Lifeward reports operating loss of USD 15.2M in Q4 2024 - Medical Buyer
Lifeward Ltd (LFWD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Lifeward Ltd. Reports Strong 2024 Revenue Growth - TipRanks
Lifeward: Q4 Earnings Snapshot - The Washington Post
Lifeward earnings missed by $0.19, revenue fell short of estimates - Investing.com South Africa
Lifeward Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Lifeward (LFWD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Lifeward Ltd Reports Q4 2024 Earnings: EPS of -$1.73 Misses Esti - GuruFocus.com
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Lifeward reports Q4 EPS ($1.73) vs (66c) last year - TipRanks
Lifeward Ltd. Reports Record Annual Revenue of $25.7 Million and Launches 2025 Sustainable Growth Plan - Nasdaq
Lifeward expects Q1 revenue to be the lowest of the year - TipRanks
Lifeward and CorLife Finalize Partnership to Expand Workers’ Compensation Access to ReWalk Exoskeleton - GlobeNewswire
Lifeward and MYOLYN expand contract for home therapy system By Investing.com - Investing.com Canada
Lifeward, MYOLYN expand partnership to enhance patient access to MyoCycle - TipRanks
Lifeward and MYOLYN expand contract for home therapy system - Investing.com India
Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use - The Manila Times
Lifeward Ltd. and MYOLYN Expand Partnership to Enhance Access to MyoCycle FES Therapy for Home Rehabilitation - Nasdaq
Lifeward and MYOLYN Expand Partnership to Enhance Patient - GlobeNewswire
Lifeward Secures Exclusive Rights to Transition MyoCycle Therapy Patients from Clinic to Home - StockTitan
Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025 - GlobeNewswire
1 Healthcare Stock to Own for Decades and 2 to Ignore - The Globe and Mail
Medical Tech Leader Lifeward Sets Date for 2024 Financial Results Reveal - StockTitan
Rehabilitation Robots Market Size Expected to Reach USD 1776.24 Mn by 2034 - GlobeNewswire Inc.
Lifeward Ltd expected to post a loss of 51 cents a shareEarnings Preview - TradingView
Lifeward CEO Larry Jasinski to step down - MSN
Lobbying Update: $15,000 of LIFEWARD (FORMERLY REWALK ROBOTICS INC.) lobbying was just disclosed - Nasdaq
Lifeward CEO Larry Jasinski to Retire - citybiz
Lifeward Ltd Stock (LFWD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):